Literature DB >> 27546044

Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.

Diego Dal Ben1, Michela Buccioni2, Catia Lambertucci2, Gabriella Marucci2, Claudia Santinelli2, Andrea Spinaci2, Ajiroghene Thomas2, Rosaria Volpini2.   

Abstract

Non-nucleoside agonists of adenosine receptors were analysed at the A2A adenosine receptor to simulate and compare their possible binding modes. The docking studies were performed by using different arrangements of the binding cavity and various docking tools. Mutagenesis results reported in literature were used as reference data for the assessment of the different ligand arrangements observed in this study. The results suggest four possible binding modes, two of which appear compatible with an agonist activity and in agreement with the mutagenesis data. This study provides useful information for the design of new simplified compounds presenting agonist activity at the A2A adenosine receptor.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  A2A Adenosine Receptor; Adenosine; Adenosine Receptor; Agonist; Docking

Mesh:

Substances:

Year:  2016        PMID: 27546044     DOI: 10.1002/minf.201501042

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  4 in total

1.  4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.

Authors:  Daniela Catarzi; Flavia Varano; Erica Vigiani; Sara Calenda; Fabrizio Melani; Katia Varani; Fabrizio Vincenzi; Silvia Pasquini; Natascia Mennini; Giulia Nerli; Diego Dal Ben; Rosaria Volpini; Vittoria Colotta
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-14

Review 2.  Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.

Authors:  Diego Dal Ben; Catia Lambertucci; Michela Buccioni; Aleix Martí Navia; Gabriella Marucci; Andrea Spinaci; Rosaria Volpini
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-08

3.  A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?

Authors:  Andrea Spinaci; Catia Lambertucci; Michela Buccioni; Diego Dal Ben; Claudia Graiff; Maria Cristina Barbalace; Silvana Hrelia; Cristina Angeloni; Seyed Khosrow Tayebati; Massimo Ubaldi; Alessio Masi; Karl-Norbert Klotz; Rosaria Volpini; Gabriella Marucci
Journal:  Molecules       Date:  2022-04-07       Impact factor: 4.927

4.  Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists.

Authors:  Daniela Catarzi; Flavia Varano; Katia Varani; Fabrizio Vincenzi; Silvia Pasquini; Diego Dal Ben; Rosaria Volpini; Vittoria Colotta
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.